New Hope for Fertility After Cancer
Young women with invasive breast cancer are often faced with a difficult choice: whether or not to undergo chemotherapy despite its risk of infertility.
Fertility Concerns for Breast Cancer Rx
Young breast cancer patients commonly have fertility concerns, and those concerns may affect their decisions about treatment.
Breast Cancer and Hormone Therapy: An Evolving Relationship
When it comes to breast cancer risk, not all hormone therapies are created equal. While some may continue to increase the risk of cancer years after a patient stops taking the medications, others can decrease the odds of getting the disease.
Breast Cancer Rx Might Prevent Early Menopause
It’s good news for young women who have had breast cancer treatment and still want a baby. A medication called goserelin may help prevent the ovarian failure often caused by chemotherapy.
Bone Loss Rx Studied for Possible Lowered Breast Cancer Risk
Previous research suggested that a common medicine used to treat osteoporosis had the positive side effect of reducing breast cancer risk. New research suggests that may not be true.
Rx Lowered Risk of Early Menopause After Chemotherapy
Researchers are constantly looking for ways to ease the lasting side effects of chemotherapy, and they may have found help for younger breast cancer patients.
Fertility Meds Didn't Cause Breast Cancer
Not all of the long-term impacts of fertility treatment are clear. But researchers have found reassuring evidence for those hoping to have a baby using such treatments.
Foods that Boost Brain Power
A few changes to your diet may give your brain a boost!
The Genetics of Menopause
Women who have mutations in the BRCA genes are at higher risk of breast and ovarian cancer. Research has suggested that women with these altered genes may also have problems conceiving children and that they go through menopause earlier than women without the defective genes.
HRT-Related Breast Cancer Risks Vary
In the late 1990s, medicines that helped women with menopausal symptoms, such as hot flashes, were widely prescribed. That changed in 2003 after a large study found that hormone replacement therapy (HRT) increased breast cancer risks.